The predictive impact of dual somatostatin receptor/fluorodeoxyglucose (FDG) positron emission tomography (PET) in metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs): review of literature and a single institution experience

Treatment with radiolabelled somatostatin analogs, a form of peptide receptor radionuclide therapy (PRRT), has changed the management of patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs). There is a subgroup of patients who have suboptimal benefit and rapidly progress on...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Amr, Asa, Sylvia L., Lee, Zhenghong, Tirumani, Sree H., Li, Qiubai, Avril, Norbert, Bajor, David, Mahipal, Amit, Chakrabarti, Sakti, Selfridge, J. Eva, Kardan, Arash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186532/
https://www.ncbi.nlm.nih.gov/pubmed/37201086
http://dx.doi.org/10.21037/jgo-22-1011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186532/
https://www.ncbi.nlm.nih.gov/pubmed/37201086
http://dx.doi.org/10.21037/jgo-22-1011

Ejemplares similares